CPRX vs GPC · P/E 18, rev $491.7M vs P/E 21, rev $12.80B
Catalyst Pharmaceuticals Inc (CPRX) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported GPC revenue for 2026-06-30 was $12.80B. Net income was $416.1M. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the CPRX and GPC stock pages for the full models.
Not investment advice.